BRKR - Bruker Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
42.09
-0.05 (-0.12%)
At close: 4:00PM EDT

41.96 -0.13 (-0.30%)
After hours: 4:18PM EDT

Stock chart is not supported by your current browser
Previous Close42.14
Open41.70
Bid42.09 x 900
Ask47.91 x 2200
Day's Range41.69 - 42.19
52 Week Range26.10 - 44.47
Volume775,091
Avg. Volume736,325
Market Cap6.599B
Beta (3Y Monthly)1.72
PE Ratio (TTM)36.01
EPS (TTM)1.17
Earnings DateJul 31, 2019 - Aug 5, 2019
Forward Dividend & Yield0.16 (0.42%)
Ex-Dividend Date2019-05-31
1y Target Est43.18
Trade prices are not sourced from all markets
  • Markit3 days ago

    See what the IHS Markit Score report has to say about Bruker Corp.

    Bruker Corp NASDAQ/NGS:BRKRView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for BRKR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BRKR. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold BRKR had net inflows of $568 million over the last one-month. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications
    PR Newswire11 days ago

    Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications

    MONTREAL, May 13, 2019 /PRNewswire/ -- At the Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM), Bruker today announced an agreement to develop the world's first 18 Tesla 11 cm bore, preclinical ultra-high field (UHF) magnetic resonance imaging (MRI) system and its clinical research applications in collaboration with the Champalimaud Foundation. This novel and unique system is expected to enable Champalimaud researchers to advance translational cancer and neuroscience research with UHF MRI and magnetic resonance spectroscopic imaging.

  • Thomson Reuters StreetEvents13 days ago

    Edited Transcript of BRKR earnings conference call or presentation 2-May-19 8:30pm GMT

    Q1 2019 Bruker Corp Earnings Call

  • Bruker Announces New $300 Million Share Repurchase Authorization and Quarterly Dividend
    PR Newswire14 days ago

    Bruker Announces New $300 Million Share Repurchase Authorization and Quarterly Dividend

    BILERICA, Mass., May 10, 2019 /PRNewswire/ -- Bruker Corporation (BRKR) today announced that on May 9, 2019, its Board of Directors approved a new share repurchase authorization for the purchase of up to $300 million of the Company's common stock over a two-year period commencing May 14, 2019. Under this authorization, the Company may repurchase its common stock from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company's repurchases may be executed using open market purchases, privately negotiated purchases or other transactions, including transactions that may be effected pursuant to trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, during the period from May 14, 2019 to May 13, 2021.

  • Bruker (BRKR) Q1 Earnings Beat Estimates, Guidance Upbeat
    Zacks15 days ago

    Bruker (BRKR) Q1 Earnings Beat Estimates, Guidance Upbeat

    Bruker's (BRKR) current focus on product development through higher R&D investment stokes investors' positive sentiment around the stock.

  • Here's Why Momentum Investors Will Love Bruker (BRKR)
    Zacks16 days ago

    Here's Why Momentum Investors Will Love Bruker (BRKR)

    Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.

  • Bruker (BRKR) Upgraded to Buy: Here's What You Should Know
    Zacks17 days ago

    Bruker (BRKR) Upgraded to Buy: Here's What You Should Know

    Bruker (BRKR) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Looking for a Growth Stock? 3 Reasons Why Bruker (BRKR) is a Solid Choice
    Zacks17 days ago

    Looking for a Growth Stock? 3 Reasons Why Bruker (BRKR) is a Solid Choice

    Bruker (BRKR) could produce exceptional returns because of its solid growth attributes.

  • Why Bruker Jumped 12.6% Today
    Motley Fool20 days ago

    Why Bruker Jumped 12.6% Today

    Anemic second-quarter financials have investors reining in their expectations.

  • Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?
    Simply Wall St.20 days ago

    Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we will run through one way of estimating the intrinsic value of Bruker Corporation (NASDAQ:BRK...

  • Bruker (BRKR) Q1 2019 Earnings Call Transcript
    Motley Fool21 days ago

    Bruker (BRKR) Q1 2019 Earnings Call Transcript

    BRKR earnings call for the period ending March 31, 2019.

  • Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates
    Zacks21 days ago

    Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

    Bruker (BRKR) delivered earnings and revenue surprises of 16.67% and 1.45%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press21 days ago

    Bruker: 1Q Earnings Snapshot

    On a per-share basis, the Billerica, Massachusetts-based company said it had profit of 20 cents. Earnings, adjusted for one-time gains and costs, came to 28 cents per share. The results surpassed Wall ...

  • Bruker Reports First Quarter 2019 Financial Results
    PR Newswire21 days ago

    Bruker Reports First Quarter 2019 Financial Results

    - Q1 2019 revenue growth of 6.9% year-over-year (yoy), organic revenue growth of 5.5% yoy; - Q1 2019 GAAP EPS of $0.20 ; Q1 2019 non-GAAP EPS of $0.28 , up 16.7% yoy; - Q1 2019 GAAP operating margin of ...

  • Bruker (BRKR) Reports Next Week: What to Know Ahead of the Release
    Zacks28 days ago

    Bruker (BRKR) Reports Next Week: What to Know Ahead of the Release

    Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Bruker Announces Date and Time of First Quarter 2019 Earnings Release and Webcast
    PR Newswirelast month

    Bruker Announces Date and Time of First Quarter 2019 Earnings Release and Webcast

    BILLERICA, Mass. , April 23, 2019 /PRNewswire/ -- Bruker (NASDAQ: BRKR) today announced it will report first quarter 2019 financial results on Thursday May 2, 2019 , after the market closes. The Company ...

  • Hedge Funds Have Never Been More Bullish On Bruker Corporation (BRKR)
    Insider Monkeylast month

    Hedge Funds Have Never Been More Bullish On Bruker Corporation (BRKR)

    It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]

  • Scientific Instruments Industry Outlook: Prospects Look Bright
    Zackslast month

    Scientific Instruments Industry Outlook: Prospects Look Bright

    Scientific Instruments Industry Outlook: Prospects Look Bright

  • Has Bruker Corporation (NASDAQ:BRKR) Got Enough Cash?
    Simply Wall St.last month

    Has Bruker Corporation (NASDAQ:BRKR) Got Enough Cash?

    Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Bruker Corporation (NASDAQ:BRKR) with a market-capitalization of US$6.2b, rarely draw their attention. However, history shows that overl...

  • Bruker Announces Further Portfolio Expansion for Microbial Identification, Infection Control and Molecular Diagnostics of Infectious Diseases
    PR Newswirelast month

    Bruker Announces Further Portfolio Expansion for Microbial Identification, Infection Control and Molecular Diagnostics of Infectious Diseases

    - Reference library expansion for broader species identification by MALDI Biotyper (MBT) - Increased speed for high-throughput projects by multi-threading MBT HT software (RUO) - Increased microbial ID ...

  • Top Ranked Growth Stocks to Buy for April 11th
    Zackslast month

    Top Ranked Growth Stocks to Buy for April 11th

    Top Ranked Growth Stocks to Buy for April 11th

  • Top Ranked Growth Stocks to Buy for April 10th
    Zackslast month

    Top Ranked Growth Stocks to Buy for April 10th

    Top Ranked Growth Stocks to Buy for April 10th

  • Top Ranked Growth Stocks to Buy for April 8th
    Zacks2 months ago

    Top Ranked Growth Stocks to Buy for April 8th

    Top Ranked Growth Stocks to Buy for April 8th